pagibaximab
Modify Date: 2024-01-19 15:49:48
pagibaximab structure
|
Common Name | pagibaximab | ||
|---|---|---|---|---|
| CAS Number | 595566-61-3 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of pagibaximabPagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis[1]. |
| Name | pagibaximab |
|---|
| Description | Pagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis[1]. |
|---|---|
| Related Catalog | |
| Target |
S. epidermidis lipoteichoic acid[1] |
| References |
| No Any Chemical & Physical Properties |